In addition, VEGF has been widely studied in relation to the development of novel drugs against CRC [96], and numerous reports have demonstrated high expression levels of VEGFA in CRC, which are associated with tumor angiogenesis, metastasis, and poor prognosis [33]. This evidence concerns the gene VEGFA and colorectal carcinoma.